+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Method, By Application , By Product (Instruments , Reagents & Kits, and Consumables), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 149 Pages
  • April 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5955220
The North America Rapid Microbiology Testing Market would witness market growth of 9.8% CAGR during the forecast period (2024-2031).

The US market dominated the North America Rapid Microbiology Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,679.3 million by 2031. The Canada market is experiencing a CAGR of 12.3% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 11.3% during (2024 - 2031).



Adopting these testing technologies has gained momentum across diverse healthcare settings, including hospitals, clinics, diagnostic laboratories, and point-of-care facilities. Healthcare providers increasingly recognize the value proposition of rapid testing in facilitating prompt diagnosis, guiding targeted therapy, and minimizing the spread of infectious diseases. These testing enables healthcare professionals to make timely clinical decisions, optimize antimicrobial therapy, and improve patient outcomes by reducing turnaround times and enhancing diagnostic accuracy.

Furthermore, this testing is instrumental in antimicrobial stewardship programs to optimize antimicrobial prescribing practices, reduce unnecessary antibiotic use, and combat antimicrobial resistance. By providing rapid susceptibility testing results, rapid testing technologies enable healthcare providers to tailor antibiotic therapy to the individual patient, select the most effective antimicrobial agents, and minimize the risk of treatment failure and antimicrobial resistance development. This proactive approach to antimicrobial stewardship helps conserve antibiotics, preserve their effectiveness, and safeguard patient safety.

The Environmental Protection Agency and other regulatory agencies in the United States mandate water quality monitoring and assessment to ensure the protection of human health and the environment. In addition, the cosmetics industry in Canada is subject to stringent regulatory standards and requirements set forth by Health Canada, the regulatory authority responsible for overseeing the safety and labeling of cosmetics marketed in the country. Adherence to regulatory requirements, including Good Manufacturing Practices (GMP) and the Cosmetic Regulations, is critical in guaranteeing cosmetic products' safety, effectiveness, and quality. As per the data provided by the International Trade Administration in 2021, the cosmetics sector in Canada generated approximately USD 1.24 billion in revenue. Industry revenue is expected to reach USD 1.8 billion by 2024. Hence, North America's rising cosmetics sector and environment testing will boost the demand for this testing in the upcoming years.

Based on Method, the market is segmented into Growth-based Rapid Microbiology Testing, Cellular Component-based Rapid Microbiology Testing, Nucleic Acid-based Rapid Microbiology Testing, Viability-based Rapid Microbiology Testing and Others. Based on Application, the market is segmented into Industrial Testing (Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics & Personal Care Products Testing and Others), Clinical Disease Diagnosis and Research Applications. Based on Product, the market is segmented into Instruments (Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems, Mass Spectrometers, PCR Systems, Bioluminescence & Fluorescence-based Detection Systems, Cytometers, Active Air Samplers and Others), Reagents & Kits, and Consumables. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Market Report Segmentation

By Method
  • Growth-based Rapid Microbiology Testing
  • Cellular Component-based Rapid Microbiology Testing
  • Nucleic Acid-based Rapid Microbiology Testing
  • Viability-based Rapid Microbiology Testing
  • Others
By Application
  • Industrial Testing
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Environmental Testing
  • Cosmetics & Personal Care Products Testing
  • Others
  • Clinical Disease Diagnosis
  • Research Applications
By Product
  • Instruments
  • Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
  • Mass Spectrometers
  • PCR Systems
  • Bioluminescence & Fluorescence-based Detection Systems
  • Cytometers
  • Active Air Samplers
  • Others
  • Reagents & Kits
  • Consumables
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Rapid Microbiology Testing Market, by Method
1.4.2 North America Rapid Microbiology Testing Market, by Application
1.4.3 North America Rapid Microbiology Testing Market, by Product
1.4.4 North America Rapid Microbiology Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Aug - 2023, May) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Rapid Microbiology Testing Market by Method
5.1 North America Growth-based Rapid Microbiology Testing Market by Country
5.2 North America Cellular Component-based Rapid Microbiology Testing Market by Country
5.3 North America Nucleic Acid-based Rapid Microbiology Testing Market by Country
5.4 North America Viability-based Rapid Microbiology Testing Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Rapid Microbiology Testing Market by Application
6.1 North America Industrial Testing Market by Country
6.2 North America Rapid Microbiology Testing Market by Industrial Testing Type
6.2.1 North America Food & Beverage Testing Market by Country
6.2.2 North America Pharmaceutical & Biological Drug Testing Market by Country
6.2.3 North America Environmental Testing Market by Country
6.2.4 North America Cosmetics & Personal Care Products Testing Market by Country
6.2.5 North America Others Market by Country
6.3 North America Clinical Disease Diagnosis Market by Country
6.4 North America Research Applications Market by Country
Chapter 7. North America Rapid Microbiology Testing Market by Product
7.1 North America Instruments Market by Country
7.2 North America Rapid Microbiology Testing Market by Instruments Type
7.2.1 North America Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
7.2.2 North America Mass Spectrometers Market by Country
7.2.3 North America PCR Systems Market by Country
7.2.4 North America Bioluminescence & Fluorescence-based Detection Systems Market by Country
7.2.5 North America Cytometers Market by Country
7.2.6 North America Active Air Samplers Market by Country
7.2.7 North America Others Market by Country
7.3 North America Reagents & Kits Market by Country
7.4 North America Consumables Market by Country
Chapter 8. North America Rapid Microbiology Testing Market by Country
8.1 US Rapid Microbiology Testing Market
8.1.1 US Rapid Microbiology Testing Market by Method
8.1.2 US Rapid Microbiology Testing Market by Application
8.1.2.1 US Rapid Microbiology Testing Market by Industrial Testing Type
8.1.3 US Rapid Microbiology Testing Market by Product
8.1.3.1 US Rapid Microbiology Testing Market by Instruments Type
8.2 Canada Rapid Microbiology Testing Market
8.2.1 Canada Rapid Microbiology Testing Market by Method
8.2.2 Canada Rapid Microbiology Testing Market by Application
8.2.2.1 Canada Rapid Microbiology Testing Market by Industrial Testing Type
8.2.3 Canada Rapid Microbiology Testing Market by Product
8.2.3.1 Canada Rapid Microbiology Testing Market by Instruments Type
8.3 Mexico Rapid Microbiology Testing Market
8.3.1 Mexico Rapid Microbiology Testing Market by Method
8.3.2 Mexico Rapid Microbiology Testing Market by Application
8.3.2.1 Mexico Rapid Microbiology Testing Market by Industrial Testing Type
8.3.3 Mexico Rapid Microbiology Testing Market by Product
8.3.3.1 Mexico Rapid Microbiology Testing Market by Instruments Type
8.4 Rest of North America Rapid Microbiology Testing Market
8.4.1 Rest of North America Rapid Microbiology Testing Market by Method
8.4.2 Rest of North America Rapid Microbiology Testing Market by Application
8.4.2.1 Rest of North America Rapid Microbiology Testing Market by Industrial Testing Type
8.4.3 Rest of North America Rapid Microbiology Testing Market by Product
8.4.3.1 Rest of North America Rapid Microbiology Testing Market by Instruments Type
Chapter 9. Company Profiles
9.1 BioMerieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 QuidelOrtho Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Trials and Approvals:
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Neogen Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product launches and Product expansions:
9.6.6 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Bruker Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Charles River Laboratories International, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Becton, Dickinson, and Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.6 SWOT Analysis

Companies Mentioned

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Methodology

Loading
LOADING...